{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:06:19Z","timestamp":1790096779675,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Primary immunodeficiencies (PIDs), a heterogenous group of inborn errors of immunity, are predetermined at birth but may evolve with age, leading to a variable clinical and laboratory presentation. In contrast, secondary immunodeficiencies (SIDs) are acquired declines of immune cell counts and or\/function. The most common type of SID is a decreased antibody level occurring as a consequence of extrinsic influences, such as an underlying condition or a side effect of some medications used to treat hematological malignancies and autoimmune disorders. Paradoxically, immune deficiencies initially attributed to secondary causes may partly be due to an underlying PID. Therefore, in the era of immune-modulating biologicals, distinguishing between primary and secondary antibody deficiencies is of great importance. It can be difficult to unravel the relationship between PID, SID and hematological malignancy or autoimmunity in the clinical setting. This review explores SID and PID crossovers and discusses challenges to diagnosis and treatment strategies. The case of an immunodeficient patient with follicular lymphoma treated with rituximab illustrates how SID in the setting of hematological cancer can mask an underlying PID, and highlights the importance of screening such patients. The risk of hematological cancer is increased in PID: for example, lymphomas in PID may be driven by infections such as Epstein-Barr virus, and germline mutations associated with PID are enriched among patients with diffuse large B-cell lymphoma. Clues suggesting an increased risk of hematological malignancy in patients with common variable immune deficiency (CVID) are provided, as well as pointers for distinguishing PID versus SID in lymphoma patients. Two cases of patients with autoimmune disorders illustrate how an apparent rituximab-induced antibody deficiency can be connected to an underlying PID. We highlight that PID is increasingly recognized among patients with autoimmune cytopenias, and provide guidance on how to identify PID and distinguish it from SID in such patients. Overall, healthcare professionals encountering patients with malignancy and\/or autoimmunity who have post-treatment complications of antibody deficiencies or other immune abnormalities need to be aware of the possibility of PID or SID and how to differentiate them.<\/jats:p>","DOI":"10.3389\/fimmu.2022.928062","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T03:24:12Z","timestamp":1658114652000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Mark","family":"Ballow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the Classification From the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.08.040","article-title":"Secondary Immunodeficiencies, Including HIV Infection","volume":"125","author":"Chinen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00033","article-title":"The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management","volume":"10","author":"Patel","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00586","article-title":"Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management","volume":"10","author":"S\u00e1nchez-Ram\u00f3n","year":"2019","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial Presenting Manifestations in 16,486 Patients With Inborn Errors of Immunity Include Infections and Noninfectious Manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in Primary Immunodeficiency Diseases: Cancer Incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary Immunodeficiency and Autoimmunity: A Comprehensive Review","volume":"99","author":"Amaya-Uribe","year":"2019","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051825","article-title":"Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jaci.2021.03.041","article-title":"Rituximab-Induced Hypogammaglobulinemia and Infection Risk in Pediatric Patients","volume":"148","author":"Labrosse","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000171","article-title":"Rituximab and Eculizumab When Treating Nonmalignant Hematologic Disorders: Infection Risk, Immunization Recommendations, and Antimicrobial Prophylaxis Needs","volume":"2020","author":"Engel","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0406-6","article-title":"The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency","volume":"37","author":"Bausch-Jurken","year":"2017","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00677-6","article-title":"A Spectrum of Clinical Findings From ALPS to CVID: Several Novel LRBA Defects","volume":"39","author":"Cagdas","year":"2019","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaci.2018.09.002","article-title":"Loss-Of-Function Mutations in Caspase Recruitment Domain-Containing Protein 14 (CARD14) Are Associated With a Severe Variant of Atopic Dermatitis","volume":"143","author":"Peled","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.662645","article-title":"Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights Into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies","volume":"9","author":"G\u00e1mez-D\u00edaz","year":"2021","journal-title":"Front Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: Monogenic Diseases Resulting in Regulatory T-Cell Deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1658523","article-title":"Malignancy in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis","volume":"15","author":"Kiaee","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B17","article-title":"Development of Cancer in Patients With Primary Immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03135","article-title":"CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID","volume":"9","author":"Kralickova","year":"2019","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01016-4","article-title":"Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency With Immune Dysregulation","volume":"41","author":"Wehr","year":"2021","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-6-571","article-title":"Secondary Antibody Deficiency - Causes and Approach to Diagnosis","volume":"16","author":"Srivastava","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections","volume":"13","author":"Casulo","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2323","article-title":"Secondary Immunodeficiency in Lymphoproliferative Malignancies","volume":"34","author":"Friman","year":"2016","journal-title":"Hematol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02912","article-title":"Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group","volume":"9","author":"Bomken","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00232","article-title":"Primary Immunodeficiencies and Oncological Risk: The Experience of the Children's Hospital of Brescia","volume":"7","author":"Maffeis","year":"2019","journal-title":"Front Pediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00769-8","article-title":"Lymphoproliferative Disease in CVID: A Report of Types and Frequencies From a US Patient Registry","volume":"40","author":"Yakaboski","year":"2020","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common Variable Immunodeficiency Disorders: Division Into Distinct Clinical Phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/bcj.2017.15","article-title":"Germline Mutations Predisposing to Diffuse Large B-Cell Lymphoma","volume":"7","author":"Leeksma","year":"2017","journal-title":"Blood Cancer J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2009.06.001","article-title":"The Search for Infectious Causes of Human Cancers: Where and Why","volume":"392","author":"Zur Hausen","year":"2009","journal-title":"Virology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses Associated With Human Cancer","volume":"1782","author":"McLaughlin-Drubin","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.07.015","article-title":"Genetic Errors of Immunity Distinguish Pediatric Nonmalignant Lymphoproliferative Disorders","volume":"149","author":"Forbes","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B31","article-title":"Epidemiology of Cancers of Infectious Origin and Prevention Strategies","volume":"56","author":"De Flora","year":"2015","journal-title":"J Prev Med Hyg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1672056","article-title":"Primary Immunodeficiencies and Lymphoma: A Systematic Review of Literature","volume":"61","author":"Herber","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01103","article-title":"Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases","volume":"9","author":"Latour","year":"2018","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and Extrinsic Causes of Malignancies in Patients With Primary Immunodeficiency Disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and Mortality in Common Variable Immune Deficiency Over 4 Decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1086\/606059","article-title":"Late-Onset Combined Immune Deficiency: A Subset of Common Variable Immunodeficiency With Severe T Cell Defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaci.2015.02.022","article-title":"Novel Mutations in TNFRSF7\/CD27: Clinical, Immunologic, and Genetic Characterization of Human CD27 Deficiency","volume":"136","author":"Alkhairy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase \u03b4 Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase \u03b4 Syndrome Registry","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","article-title":"Combined Immunodeficiency and Epstein-Barr Virus-Induced B Cell Malignancy in Humans With Inherited CD70 Deficiency","volume":"214","author":"Abolhassani","year":"2017","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant Mutations in the Autoimmune Regulator AIRE Are Associated With Common Organ-Specific Autoimmune Diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and Inflammatory Manifestations Occur Frequently in Patients With Primary Immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","article-title":"Clinical, Immunologic, and Molecular Spectrum of Patients With LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review","volume":"7","author":"Habibi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, Penetrance, and Treatment of 133 Cytotoxic T-Lymphocyte Antigen 4-Insufficient Subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-Term Outcome of LRBA Deficiency in 76 Patients After Various Treatment Modalities as Evaluated by the Immune Deficiency and Dysregulation Activity (IDDA) Score","volume":"145","author":"Tesch","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000833","article-title":"Autoimmunity as a Continuum in Primary Immunodeficiency","volume":"31","author":"Walter","year":"2019","journal-title":"Curr Opin Pediatr"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e27619","DOI":"10.1002\/pbc.27619","article-title":"Primary Immune Regulatory Disorders for the Pediatric Hematologist and Oncologist: A Case-Based Review","volume":"66","author":"Chandrakasan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B47","unstructured":"Primary Immune Deficiency Treatment Consortium (PIDTC): Primary Immune Regulatory Disorders (PIRD)2019"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-Of-Function Nuclear Factor kb Subunit1 (NFKB1) Variants are the Most Common Monogenic Cause of Common Variable Immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes Associated With Common Variable Immunodeficiency: One Diagnosis to Rule Them All","volume":"53","author":"Bogaert","year":"2016","journal-title":"J Med Genet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8645-0","article-title":"Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing","volume":"54","author":"Ameratunga","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.007","article-title":"Prevalence and Clinical Challenges Among Adults With Primary Immunodeficiency and Recombination-Activating Gene Deficiency","volume":"141","author":"Lawless","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans Syndrome Is Associated With a High Frequency of Potentially Damaging Variants in Immune Genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649182","article-title":"Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort","volume":"12","author":"Westermann-Clark","year":"2021","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical Guidance for the Diagnosis and Management of Secondary Hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees","volume":"149","author":"Otani","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13580","article-title":"Treating Secondary Antibody Deficiency in Patients With Haematological Malignancy: European Expert Consensus","volume":"106","author":"Jolles","year":"2021","journal-title":"Eur J Haematol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41467-019-14225-8","article-title":"Machine Learning can Identify Newly Diagnosed Patients With CLL at High Risk of Infection","volume":"11","author":"Agius","year":"2020","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880115)61:2<279::aid-cncr2820610215>3.0.co;2-4","article-title":"Serum Immunoglobulins in B-Chronic Lymphocytic Leukemia","volume":"61","author":"Rozman","year":"1988","journal-title":"Natural History Prognostic Significance Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13288","article-title":"A New Risk Model to Predict Time to First Treatment in Chronic Lymphocytic Leukemia Based on Heavy Chain Immunoparesis and Summated Free Light Chain","volume":"103","author":"Tadmor","year":"2019","journal-title":"Eur J Haematol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012924","article-title":"T-Follicular Helper Cell Expansion and Chronic T-Cell Activation Are Characteristic Immune Anomalies in Evans Syndrome","volume":"139","author":"Kumar","year":"2022","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.928062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T03:24:18Z","timestamp":1658114658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.928062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2022.928062"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.928062","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"article-number":"928062"}}